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BJNhem20–OCIAD1-OV line was generated by transfection of
BJNhem20 human embryonic stem cells (hESCs) with pCAG-OCIAD1
construct using microporation technique with the conditions of
1100 V, 20 ms pulse width and 2 pulses. The pCAG-OCIAD1 construct
was generated by cloning OCIAD1 Open Reading Frame amplicon fromamino acids 1–245 between Xho1 and Not1 sites using appropriate
primers. A stable hESC line was generated after subjecting these
transfected cells to puromycin selection for two weeks.
OCIAD1 overexpression was validated by immunostaining and
Western blotting in three biological replicates.
Expression of pluripotent stem cell markers OCT4, SSEA3/4 and
TRA1-81 has been shown by immunostaining. Differentiation of these
hESC lines to all the three germ layers was demonstrated by immuno-
staining for different markers such as AFP (endoderm), Brachyury
(mesoderm) and β-III tubulin (ectoderm). Karyotype was also checked
in these cells and found to be normal.
3. Materials and methods
3.1. Cell culture
hESC line BJNhem20 was derived from discarded Grade III embryos
and tested for pluripotency (Inamdar et al., 2009). This cell line has
been cultured continuously for over 200 passages without acquiring
any karyotypic abnormality (Venu et al., 2010). The cell linewas includ-
ed in the analysis of genetic stability in the International Stem Cell
Initiative project (ISCI2, 2011). Cultures of BJNhem20 and the transgen-
ic line BJNhem20–OCIAD1-OV were maintained on mouse embryonic
ﬁbroblast feeder layers in hESC medium composed of KnockOut
Dulbecco's modiﬁed Eagle medium (KO-DMEM—Life Technologies Cat
no. 10829-018) supplemented with 20% KnockOut Serum replacement
(KOSR—Life Technologies Cat no. 10828-028), 1% GlutaMAX (Life Tech-
nologies Cat no. 35050-061), 1% non-essential amino acids (MEM-
NEAA-Life Technologies Cat no. 11140-050), 0.1% β-mercaptoethanol
(Life Technologies Cat no. 21985-023) and 8 ng/ml human recombinant
basic ﬁbroblast growth factor (human bFGF—Sigma Aldrich Pvt. Ltd. Cat
no. F-0291).These cells were routinely passaged by mechanical cutting
of undifferentiated colonies.
Fig. 1. Expression and karyotype analysis of BJNhem20–OCIAD1-OV hESC line: (A)Western blot analysis showing overexpression of OCIAD1 in the OVhESC line as compared towild type.
Graph represents standard error mean after analysis of three biological replicates using single factor ANOVA (P value 0.003). (B) Analysis of transcript levels of pluripotencymarker genes
Oct4,Nanog, TDGF and Sox2 by reverse transcription andpolymerase chain reaction (RT-PCR) ampliﬁcation.GAPDHwas used to normalize transcript levels. (C) Immunostaining analysis of
OCIAD1-OV for overexpression of OCIAD1 and for pluripotencymarkers Oct4, SSEA4 and TRA1-81 as indicated, compared to parental line BJNhem20 hESC line. (D) Karyotypic normality
validation of BJNhem20–OCIAD1-OV. (E) Differentiation analysis of BJNhem20–OCIAD1-OV: Embryoid bodies stained to show differentiation to all the three germ layers by
immunostaining for AFP, Brachyury and βIII-Tubulin marking the endoderm, mesoderm and ectoderm respectively.
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For microporation, BJNhem20 cells were grown onMatrigel (Becton
Dickinson Catalogue No. 354277) coated dishes till they were 60–70%
conﬂuent. The cells were trypsinized with 1X TrypLE (Life Technologies
Cat No. 12605-010) at 37 °C for 4min. The cells were pelleted by centri-
fugation at 1000 rpm for 2min andwashedwith phosphate buffered sa-
line and enumerated. 0.5 million cells were resuspended in 10 μl of R
buffer and 6 μg of DNA was mixed and the cells were transfected in a
microporator (Neon Microporation Kit — Life Technologies Cat no.
MPK1096). Microporation conditions used were 1100 V, 20 ms and
2 pulses according to the manufacturer's instructions. The cells were
then directly seeded onto Matrigel-coated dishes with mTESR media
(StemCell Technologies Cat no. 05850) supplementedwith ROCK inhib-
itor (10 μM Y-27632, Sigma Aldrich Pvt. Ltd. Cat no. Y0503) to aid the
survival of single cells. mTESR medium without ROCK inhibitor was
used after 12–16 hwhen the cells adhered. 48 h after transfection, puro-
mycin (0.5 μg/ml Sigma Aldrich Pvt. Ltd. P8833) was added to the
transfected culture and selection was continued for 10 days. Puromycin
resistant individual clones of transgenic OCIAD1 overexpressing hESCs
were manually picked and passaged. BJNhem20–OCIAD1-OV cells
were subsequently cultured in both feeder free conditions on Matrigel
in the presence of mTESR medium and on feeders with regular hESC
medium.3.3. Embryoid body differentiation
Differentiation of embryoid bodies was carried out as described be-
fore (Inamdar et al., 2009). Brieﬂy, colonies grown on MEFs were me-
chanically cut and pieces cultured in human embryoid body media
(10% FBS- Hyclone-SH30070 with β-mercaptoethanol and GlutaMAX
in DMEM) on low attachment plates. These hESC aggregates wereallowed to grow in suspension for 3 days after which the colonies
formed embryoid body-like structures and were transferred to the tis-
sue culture dishes pre-treated with 0.1% gelatin and allowed to attach
and differentiate spontaneously till the time for harvest from day 6
onwards for immunostaining analyses.
3.4. Immunostaining
hESC and hEBs were ﬁxed in 2% paraformaldehyde (in PBS), perme-
abilized with Triton-X 100 (0.1% for cells and 0.3% for EBs) and then
blocked with 4% FBS for 1 h at RT (Room Temperature). Post blocking,
cells were incubatedwith the appropriate primary antibodies overnight
at 4 °C, thenwere washedwith PBS at RT and incubatedwith secondary
antibody conjugated to either Alexa Fluor 488 or 568 for 1 h at RT (Dilu-
tion 1:400 Invitrogen). The cells were washed and stained using DAPI
(1:500 inM1 buffer Invitrogen) to visualize nuclei. The images were ac-
quired using an epiﬂuorescence microscope (IX-81 microscope system
(Olympus)) ﬁtted with a cooled CCD camera (CoolSnap, Roper Scientif-
ic). Primary antibodies used were against OCIAD1 (Abcam Ab91574),
Oct4 (BD Biosciences BD 611203), TRA1-81 and SSEA4 monoclonal an-
tibodies were a kind gift from Peter Andrews (University of Shefﬁeld,
UK), Brachyury (Santa Cruz Biotech Cat no. SC-17743), β-III tubulin,
AFP (Sigma Chemical Pvt. Ltd. Cat no. A8452).
3.5. RNA isolation/cDNA synthesis and PCR
Total RNA was extracted from cells by TRIzol reagent (Life Technol-
ogies Cat no. 15596-026) following themanufacturer's instructions. 2 μg
of DNase treated RNA was converted to cDNA by performing reverse
transcription using Superscript II (Life Technologies Cat no. 18064-
014). Primer sequences used for cDNA ampliﬁcation (5′-3′) were the
following:
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GSequenceCT4_F GAAGGTATTCAGCCAAACGAC
CT4_R GTTACAGAACCACACTCGGA
ANOG_F TGCAAATGTCTTCTGCTGAGAT
ANOG_R GTTCAGGATGTTGGAGAGTTC
APDH_F GTCCATGCCATCACTGCCA
APDH_R TTACTCCTTGGAGCCATGG4. Veriﬁcation of karyotype
Standard G banding of metaphase spreads was performed and
analyzed using CytoVision software. For each sample, at least 50
metaphases were counted and 10 were analyzed.
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